IL313677A - Fitusiran for use in improving patient-reported outcome in hemophilia patients - Google Patents
Fitusiran for use in improving patient-reported outcome in hemophilia patientsInfo
- Publication number
- IL313677A IL313677A IL313677A IL31367724A IL313677A IL 313677 A IL313677 A IL 313677A IL 313677 A IL313677 A IL 313677A IL 31367724 A IL31367724 A IL 31367724A IL 313677 A IL313677 A IL 313677A
- Authority
- IL
- Israel
- Prior art keywords
- phytosiran
- hemophilia
- patients
- improving outcomes
- outcomes reported
- Prior art date
Links
- 208000031220 Hemophilia Diseases 0.000 title 1
- 208000009292 Hemophilia A Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293070P | 2021-12-22 | 2021-12-22 | |
| US202263305550P | 2022-02-01 | 2022-02-01 | |
| US202263335535P | 2022-04-27 | 2022-04-27 | |
| US202263359717P | 2022-07-08 | 2022-07-08 | |
| US202263382223P | 2022-11-03 | 2022-11-03 | |
| US202263386489P | 2022-12-07 | 2022-12-07 | |
| PCT/US2022/082213 WO2023122713A1 (en) | 2021-12-22 | 2022-12-22 | Fitusiran for use in improving patient-reported outcome in hemophilia patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL313677A true IL313677A (en) | 2024-08-01 |
Family
ID=85227438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL313677A IL313677A (en) | 2021-12-22 | 2022-12-22 | Fitusiran for use in improving patient-reported outcome in hemophilia patients |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250064842A1 (https=) |
| EP (1) | EP4452280A1 (https=) |
| JP (1) | JP2025500412A (https=) |
| KR (1) | KR20240138572A (https=) |
| AU (1) | AU2022419588A1 (https=) |
| CA (1) | CA3243297A1 (https=) |
| IL (1) | IL313677A (https=) |
| MX (1) | MX2024007894A (https=) |
| TW (1) | TW202342065A (https=) |
| WO (1) | WO2023122713A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025171279A1 (en) * | 2024-02-09 | 2025-08-14 | Genzyme Corporation | Treatment of hemophilia with fitusiran |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9127274B2 (en) | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| KR20180095843A (ko) | 2015-12-07 | 2018-08-28 | 젠자임 코포레이션 | Serpinc1-연관 장애의 치료를 위한 방법 및 조성물 |
| TW202434265A (zh) | 2017-07-10 | 2024-09-01 | 美商健贊公司 | 於患有血友病之個體中治療出血事件之方法及組成物 |
| WO2022120291A1 (en) * | 2020-12-06 | 2022-06-09 | Genzyme Corporation | Treatment of hemophilia with fitusiran |
-
2022
- 2022-12-21 TW TW111149131A patent/TW202342065A/zh unknown
- 2022-12-22 KR KR1020247024462A patent/KR20240138572A/ko active Pending
- 2022-12-22 EP EP22857063.6A patent/EP4452280A1/en active Pending
- 2022-12-22 AU AU2022419588A patent/AU2022419588A1/en active Pending
- 2022-12-22 MX MX2024007894A patent/MX2024007894A/es unknown
- 2022-12-22 CA CA3243297A patent/CA3243297A1/en active Pending
- 2022-12-22 US US18/723,352 patent/US20250064842A1/en active Pending
- 2022-12-22 WO PCT/US2022/082213 patent/WO2023122713A1/en not_active Ceased
- 2022-12-22 JP JP2024537896A patent/JP2025500412A/ja active Pending
- 2022-12-22 IL IL313677A patent/IL313677A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202342065A (zh) | 2023-11-01 |
| JP2025500412A (ja) | 2025-01-09 |
| AU2022419588A1 (en) | 2024-08-01 |
| MX2024007894A (es) | 2024-08-20 |
| US20250064842A1 (en) | 2025-02-27 |
| EP4452280A1 (en) | 2024-10-30 |
| WO2023122713A1 (en) | 2023-06-29 |
| KR20240138572A (ko) | 2024-09-20 |
| CA3243297A1 (en) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTC2459208I2 (lt) | Terapiniai agentai, skirti prieskydinės liaukos hormono lygio sumažinimui | |
| CY20152200002T2 (el) | Μονοθεραπεια (psi-7977) ή συνδυαστικη θεραπεια με daas για χρηση στην αντιμετωπιση του hcv | |
| DK2912074T3 (da) | Dermal injicerbar steril sammensætning | |
| BR302013006822S1 (pt) | Configuração aplicada em curativo médico. | |
| IL234028A0 (en) | Catheter for the treatment of atrial flutter having single action dual deflection mechanism | |
| PL2766040T3 (pl) | Pertuzumab, trastuzumab, docetaksel i karboplatyna w leczeniu wczesnego stadium raka piersi | |
| EP2929436A4 (en) | STOP CRITERIA FOR HISTORIZED ITERATIVE ERROR CORRECTION | |
| ME02914B (me) | Novi terapeutski agensi | |
| BRDI7106721S (pt) | Configuração aplicada em instrumento médico | |
| BR112015004370A2 (pt) | composição esterilizada, processo de fabricação da mesma, utilização da mesma, e, kit | |
| BRDI7103743S (pt) | Configuração aplicada em instrumento médico | |
| EP2967876A4 (en) | REMOVABLE REINFORCEMENT FOR A MEDICAL IMPLANT | |
| HRP20190122T1 (hr) | Protutijelo protiv adrenomedulina (adm) ili fragment protutijela protiv adm ili okosnica ne-ig protiv adm, namijenjeni reguliranju ravnoteže tekućina kod pacijenta s kroničnom ili akutnom bolešću | |
| EA201590883A1 (ru) | Лечение помалидомидом рака у субъекта с почечной недостаточностью | |
| IL289787A (en) | Antibody combinations for treatment of cancer in specific patients | |
| UY34043A (es) | Isoxazolinas como agentes terapéuticos | |
| EA201590503A1 (ru) | Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями | |
| CO6920289A2 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib. | |
| EP2661341A4 (en) | LATTICE CUTTING MACHINE | |
| DK3003363T3 (da) | Immunogen sammensætning til anvendelse i terapi | |
| MX374220B (es) | Nepentesina para usarse en el tratamiento de la intolerancia al gluten y padecimientos relacionados. | |
| IL313677A (en) | Fitusiran for use in improving patient-reported outcome in hemophilia patients | |
| DE102013202503A8 (de) | Instrument, insbesondere medizinisch-endoskopisches Instrument oder Technoskop | |
| IT1404469B1 (it) | Guida deformabile per divisori in genere | |
| HUE043419T2 (hu) | Vegyületek remielinizációs blokk kezelésére HERV-W borítékfehérje expresszióval járó betegségekben |